(Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)
NCT03848078 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 598
Last updated 2021-02-25
Summary
A multi-centre randomized non-inferiority trial investigating the (cost-)effectiveness of Optical Coherence Tomography (OCT) versus regular punch biopsy in the diagnosis and subtyping of Basal Cell Carcinoma (BCC).
Conditions
- Basal Cell Carcinoma
- Optical Coherence Tomography
Interventions
- DEVICE
-
Optical Coherence Tomography
OCT is an imaging technique, which is able to produce real-time, in vivo, cross-sectional images of lesions with a depth of 1,5-2 mm. OCT imaging is based on light-interferometry, calculating the interference of an optical beam reflected by the tissue with a reference. In such ways, microscopic details of lesions and tissues can be visualized. This information can be used to identify a lesion as BCC, and to specify the subtype. Therefore, we assume that the use of the OCT might reduce the number of biopsies and the accompanying morbidity. The investigator scans 6mm of skin with the OCT (30 seconds) and decides whether the lesion is a BCC or not.
Sponsors & Collaborators
-
ZonMw: The Netherlands Organisation for Health Research and Development
collaborator OTHER -
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Klara Mosterd, MD, PhD · Maastricht University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-26
- Primary Completion
- 2021-08-31
- Completion
- 2021-10-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies
NCT03880097 ·Status: NOT_YET_RECRUITING
-
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
NCT00535184 ·Status: COMPLETED
-
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT04799535 ·Status: RECRUITING
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Early Detection of Breast Cancer Using Tomosynthesis Imaging
NCT00637598 ·Status: COMPLETED ·Phase: NA
-
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678 ·Status: COMPLETED
-
Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer
NCT03289195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
NCT03580837 ·Status: UNKNOWN
-
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
NCT00535327 ·Status: COMPLETED
-
KVUS at Neoadjuvant CTx of Breast Cancer
NCT03385200 ·Status: UNKNOWN ·Phase: PHASE3
-
Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography
NCT03842358 ·Status: COMPLETED ·Phase: NA
-
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
NCT01864083 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Whole-body MRI for the Detection of Metastasis
NCT02183597 ·Status: WITHDRAWN
-
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
NCT03650803 ·Status: COMPLETED ·Phase: NA
-
HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
NCT06369831 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
NCT03511859 ·Status: UNKNOWN
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography
NCT03377036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer
NCT01018251 ·Status: WITHDRAWN ·Phase: NA
-
Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer
NCT02058758 ·Status: COMPLETED
-
MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer
NCT00978770 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
NCT00437879 ·Status: RECRUITING
-
Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)
NCT03876951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA